http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7407673-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8cffff110f1dedee14e85b745504dce http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ac2fefc0d416d4ba3a0994beb07d18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd173cc4a706f46d9d4cc38fef6a89ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1e589a952b1a5e40748038d389f88fe |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N59-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12 |
| filingDate | 2003-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4af9a783e61ab096358e5cb67e9ff3dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf9e2acb9ccfa630dff434efe56b53d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c69f6717bdebe85abe6354b4c5d81dbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cdd85ea6af116d447df11214dad125b |
| publicationDate | 2008-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-7407673-B2 |
| titleOfInvention | Radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof |
| abstract | The present invention relates to radioactive magnetic fluids, process for preparing them and use thereof. Particularly, the present invention relates to the radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof. n The radioactive magnetic fluids of the present invention include the component of Cu 2+ which radiates a β-ray and γ-ray. The β radiation can effectively kill the tumor cells. Since the γ radiation are easily imaged with γ-camera, the magnetic fluids can be gathered to the treatment site with the radiograph under external magnetic field. Therefore, the radioactive magnetic fluids of the present invention can be used for treatment of cancer with minimal side effects. Also, the tightly bonded decanoic acid and nonanoic acid layer of the present invention not only increase particle-particle repulsion but also take hydrophilicity, to disperse homogeneously and stably the magnetic nanoparticles in water. Also, carboxylic acid of the surfactant is exposed to outside, to prevent the magnetic nanoparticles from being oxidized by air. n Therefore, the radioactive magnetic fluids can be used as therapeutic drug or diagnostic reagent for cancer. |
| priorityDate | 2003-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.